BIOMILQ

BIOMILQ is a Durham, North Carolina-based biotechnology company pioneering the production of functional cell-cultured human milk components.

We are revolutionizing early-life nutrition by developing a science-led, women-owned solution that leverages our patented technology to create a more sustainable and accessible alternative to traditional infant formula.

BIOMILQ’s approach addresses the critical need for more of the benefits of breast milk in infants, particularly those who cannot breastfeed. Our technology offers a scalable and ethical pathway to bridging the gap between breast milk and infant nutrition, contributing to improved infant health outcomes and supporting families worldwide.

Founded in 2019, BIOMILQ is rapidly advancing its research and development, with a team of dedicated scientists and a commitment to social impact. We are focused on expanding the applications of our technology to address broader nutritional needs and improve maternal and infant health globally.